Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

The EVICEL® Gastrointestinal Study

ClinicalTrials.gov ID: NCT01589822

Public ClinicalTrials.gov record NCT01589822. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Single Blind, Randomized, Controlled Study to Evaluate the Safety and Effectiveness of EVICEL® as an Adjunct to Gastrointestinal Anastomosis Techniques

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and effectiveness of EVICEL® Fibrin Sealant (Human) for use as an adjunct to gastrointestinal (GI) surgery.

Study identification

NCT ID
NCT01589822
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ethicon, Inc.
Industry
Enrollment
214 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2012 (Type not available)
Primary completion
Jan 2014 (Actual)
Completion
Sep 2014 (Actual)
Last update posted
Feb 25, 2015

2012 – 2014

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Clinical Investigation Site #1 Irvine California 92868 —
Clinical Investigation Site #2 Jacksonville Florida 32099 —
Clinical Investigation Site #5 Augusta Georgia 30912 —
Clinical Investigation Site #4 New Orleans Louisiana 70121 —
Clinical Investigation Site #8 Portland Oregon 97239 —
Clinical Investigation Site #23 Greenville South Carolina 29605 —
Clinical Investigation Site #3 Houston Texas 77030 —
Clinical Investigation Site #6 Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01589822, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 25, 2015 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01589822 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →